Literature DB >> 10630854

Early tangential excision and skin grafting of moderate burns is superior to honey dressing: a prospective randomised trial.

M Subrahmanyam1.   

Abstract

METHODS: In this prospective trial, 50 burn patients were randomised to be treated either with early tangential excision and skin grafting or by the application of honey dressings, with delayed skin grafting as necessary. The 25 patients in the tangential excision (TE) group had burns of 23 +/- 4%, 12% of which was full thickness. The honey treated patients (HT), (N=25), had burns of 24 + 4%, 13% of which was full thickness. Seventeen of the TE patients were operated upon on day 3, the remainder before day 6 post burn. Eleven of the HT patients eventually required skin grafting. Cosmetic and functional results were assessed at 3 months post discharge.
RESULTS: In the TE group, the skin grafting take rate was 99 +/- 3%. In the HT group, the graft take rate was 74 +/- 18% (P < 0.01). The mean percentage of blood volume replaced was 35 +/- 12% in TE patients vs. 21 +/- 15% in HT patients (P < 0.01). Only one TE patient died due to status asthmaticus, while there were 3 deaths, all from sepsis, in the HT patients. At 3 month follow-up, 92% of the TE patients had good to excellent functional and cosmetic results vs. 55% in HT patients, 3 of whom had significant contractures.
CONCLUSION: Early tangential excision and skin grafting was clearly superior to expectant treatment using topical honey in patients with moderate burns in this randomised, prospective study performed at a General Hospital in the Indian subcontinent. The availability of suitable allogenic blood is a potential problem when TE is employed.

Entities:  

Mesh:

Year:  1999        PMID: 10630854     DOI: 10.1016/s0305-4179(99)00063-7

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  15 in total

1.  Topical application of honey for burn wound treatment - an overview.

Authors:  M Subrahmanyam
Journal:  Ann Burns Fire Disasters       Date:  2007-09-30

2.  Commercial dressings for burns versus sweet ancient remedy.

Authors:  Livia Puljak; Lorenzo Moja; Gian Franco Gensini; Roberto Gusinu; Andrea A Conti
Journal:  Intern Emerg Med       Date:  2009-02       Impact factor: 3.397

3.  Histological assessment of tangentially excised burn eschars.

Authors:  Reuven Gurfinkel; Lior Rosenberg; Sarit Cohen; Arnon Cohen; Alex Barezovsky; Emanuela Cagnano; Adam J Singer
Journal:  Can J Plast Surg       Date:  2010

Review 4.  Antiseptics for burns.

Authors:  Gill Norman; Janice Christie; Zhenmi Liu; Maggie J Westby; Jayne M Jefferies; Thomas Hudson; Jacky Edwards; Devi Prasad Mohapatra; Ibrahim A Hassan; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

5.  Early excision and grafting versus delayed excision and grafting of deep thermal burns up to 40% total body surface area: a comparison of outcome.

Authors:  M Saaiq; S Zaib; S Ahmad
Journal:  Ann Burns Fire Disasters       Date:  2012-09-30

Review 6.  Up-to-date use of honey for burns treatment.

Authors:  A Zbuchea
Journal:  Ann Burns Fire Disasters       Date:  2014-03-31

7.  Immediate tangential excision accelerates wound closure but does not reduce scarring of mid-dermal porcine burns.

Authors:  L K Macri; A J Singer; S A McClain; L Crawford; A Prasad; J Kohn; R A F Clark
Journal:  Ann Burns Fire Disasters       Date:  2016-03-31

Review 8.  Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology.

Authors:  Arne Simon; Kai Sofka; Gertrud Wiszniewsky; Gisela Blaser; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2005-08-02       Impact factor: 3.603

9.  Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.

Authors:  Jeff S Isenberg; Loretta K Pappan; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; David A Wink; William A Frazier; David D Roberts
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

10.  Antibacterial honey (Medihoney) for wound care of immunocompromised pediatric oncology patients.

Authors:  Arne Simon; Kai Sofka; Gertrud Wieszniewsky; Gisela Blaser
Journal:  GMS Krankenhhyg Interdiszip       Date:  2006-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.